Full-Service Contract
Development and Manufacturing
S Kant Healthcare is a premier CDMO partner, offering end-to-end contract development
and manufacturing services fortheregulated and emerging pharmaceutical markets worldwide.
Certified Manufacturing Excellence
Our finished formulation facility is certified by EU-GMP and WHO-Prequalified (WHO-PQ), ensuring your products meet the highest international quality standards.
We focus on general category, non-beta-lactam formulations across the following dosage forms, all under one single roof:
| Dosage Form | Capabilities | ||
|---|---|---|---|
|
Oral Solids |
Tablet, Capsule, Dry Powder for Suspension |
||
|
Oral Liquids |
Syrup, Solution, Suspension |
||
|
Semi-Solids |
Ointment, Cream, Gel, Oral Gel |
Packaging Capabilities
22 Packing Lines across multiple dosage forms
Track & Trace Ready for FMD Compliance with TE Stickering
Pharmacode Readers, Blister Inspection Systems, Auto Weight Checkers
High Speed cartonators for packing of patient packs
Operational Flexibility and Scalability:
Tailored to Your Needs
S Kant Healthcare is uniquely positioned to handle the dynamic demands of pharmaceutical product development and manufacturing. Our operational model is built on two core pillars: flexibility and scalability.
Agile Capacity Management: Our facility boasts multiple, independent manufacturing blocks. This modular design allows us to dedicate specific resources and lines to different project sizes and complexities without compromising efficiency or quality
Seamless Batch Progression: We support your product at every stage, offering:
- Exhibit Batches: Precise, small-scale runs for critical regulatory submissions.
- Mid-Size Commercial Launch Batches: Strategic volumes designed for effective market entry and early commercialization.
- Large-Scale Commercial Batches: Robust capacity to meet high market demand and sustain ongoing supply.
Adaptable Processes: Our experienced teams and integrated quality management system ensure that we can swiftly adjust to changing project scopes, market conditions, or regulatory requirements, providing you with a responsive and reliable manufacturing partner.
This inherent capability for flexibility and scalability means you gain a partner who can grow with your product, minimizing risks and optimizing your path from clinical development to a successful market presence.
Production Capacities
Oral Solids
Annual Capacities:
- Tablets : 3.5 Bil Units.
- Capsules: 600 Mil Units.
- Dry Powder : 20 Mil Units.
Dedicated Pilot Plant / Mfg Line For Scale Up / Tech Transfer / Exhibit Batches
Packing Lines for Blister, Strip & Bulk Packing.
Oral Liquids
Annual Capacities:
- Clear Syrup : 75 Mil Bottles.
- Oral Suspension : 75 Mil Bottles.
Dedicated Pilot Plant / Mfg Line For Scale Up / Tech Transfer / Exhibit Batches
Packing Lines for Glass. HDPE & Pet Bottles with ROPP & CRC Capping
Semi Solids
Annual Capacities:
- Ointment, Cream, Gel 100 Mil Tubes.